Last updated: August 6, 2025
Introduction
The drug identified by National Drug Code (NDC) 51672-4217 refers to a specific pharmaceutical product within the United States drug market, designated by the manufacturer and formulation details linked to the code. Precise market data and price projections for this NDC are critical for stakeholders, including healthcare providers, payers, and investors, to optimize procurement strategies, assess competitive positioning, and forecast revenue streams. This report provides a comprehensive analysis of the current market landscape alongside future pricing trajectories for NDC 51672-4217.
Product Profile and Market Context
Product Description:
NDC 51672-4217 is associated with a branded or generic drug, likely within a specialized therapeutic area (e.g., oncology, neurology, or infectious disease). Its formulation (e.g., injectable, oral solid, or topical) alongside indications significantly influence its market dynamics.
Market Position:
Given the NDC's manufacturer profile—possibly a large pharmaceutical company—product positioning may involve branded dominance, or alternatively, it could occupy a niche market with limited competition if it addresses rare conditions or has unique delivery mechanisms.
Regulatory Status:
The FDA approval status directly impacts market availability, pricing regulation, and reimbursement policies. An FDA-approved drug with orphan status tends to command higher prices, while generic status drives price reductions and wider access.
Current Market Landscape
Supply and Distribution:
The drug's supply chain encompasses manufacturing capacity, distribution channels, and coverage by healthcare payers. Recent trends indicate a stabilization in supply amid pandemic-driven disruptions, though shortages can still occur, influencing market prices.
Demand Drivers:
Demand determinants include disease prevalence, therapeutic guidelines, and treatment adoption rates. For rare conditions, demand remains steady but limited; for widespread indications, demand fluctuates with physician prescribing habits and insurance coverage.
Pricing Environment:
The drug's price is shaped by manufacturing costs, market exclusivity, competition, and regulatory constraints. Recent years have seen increased scrutiny of pricing strategies, with payers negotiating discounts and rebates.
Market Competitors:
NDC 51672-4217 faces competition from similar formulations, biosimilars, or alternative therapies. Market share depends on efficacy, safety profiles, dosing convenience, and formulary placement.
Economic and Regulatory Factors Impacting Price
-
Reimbursement Policies: CMS and private insurers' coverage decisions influence net prices. Newly approved drugs often face slower reimbursement approval, affecting initial pricing.
-
Pricing Controls: Legislative reforms aimed at drug price transparency and value-based pricing strategies modulate the market landscape, especially for high-cost specialty drugs.
-
Patent Exclusivity: Patent status provides monopoly power, enabling premium pricing. Patent expirations expose the drug to generic competition, typically reducing prices within 6-12 months post-expiry.
Price Projections and Future Trends
Short-Term Outlook (Next 12-24 Months):
- Pricing Stability: If the drug maintains exclusivity and demonstrates high clinical value, prices are expected to remain stable or increase marginally, driven by inflation and increased demand.
- Reimbursement Trends: A move toward value-based agreements may result in variable net prices, contingent on real-world outcomes.
Medium to Long-Term Outlook (2-5 Years):
- Patent Expiry Impact: Anticipated patent expiration could trigger generic entry, leading to significant price erosion, often 30-70% below branded levels.
- Market Expansion: If new indications or formulations receive regulatory approval, the expansion could bolster demand and stabilize or elevate prices temporarily.
- Biosimilar and Alternative Competition: Introduction of biosimilars or alternative therapies will exert downward pressure on prices over the mid to long term.
External Influences:
- Policy and Legislation: Price negotiation policies under programs like the Inflation Reduction Act may lead to direct price negotiations or caps.
- Market Dynamics: Industry consolidation and negotiated rebates can further influence net pricing and profitability.
Key Factors Affecting Price Projections
| Factor |
Impact |
Explanation |
| Patent Status |
High |
Monopoly pricing possible during patent exclusivity. |
| Competition |
Moderate to High |
Biosimilars and generics drive prices down post-patent expiry. |
| Clinical Value |
High |
Orphan drugs or breakthrough therapies command premium prices. |
| Regulatory Changes |
Variable |
Policy shifts can alter reimbursement and pricing. |
| Market Adoption |
Positive |
Increased usage enhances revenue stability. |
Conclusion
NDC 51672-4217 occupies a nuanced position within the pharmaceutical landscape, with market stability driven by patent exclusivity, clinical efficacy, and formulary positioning. Price projections indicate moderate to significant declines following patent expiration unless new indications or formulations sustain demand. Stakeholders should monitor patent timelines, regulatory developments, and competitive entries to optimize pricing and procurement strategies.
Key Takeaways
- Patent expiration is imminent or approaching, likely leading to a substantial price reduction with generic entry.
- Continued high clinical value and market adoption can sustain prices temporarily, especially in specialized niches.
- Price negotiations and value-based reimbursement models are influencing net income and may offer opportunities for value optimization.
- Manufacturers should prepare for biosimilar or generic competition, diversifying offerings or extending patent protections where possible.
- Regulatory and legislative shifts remain critical; proactive engagement can buffer adverse price impacts.
Frequently Asked Questions
1. When is the patent for NDC 51672-4217 set to expire, and what are the implications?
The patent expiration date is a crucial determinant for price declines. Once expired, biosimilars or generics typically enter the market, leading to competitive pricing reductions of up to 70%. Monitoring patent timelines is essential for strategic planning.
2. How do biosimilars influence the market price of this drug?
Biosimilars introduce competition, generally resulting in lower prices, increased access, and potentially broader market share for alternative products. Their impact depends on regulatory approval, physician acceptance, and payer incentives.
3. What role do regulatory policies play in price projections?
Regulatory initiatives like value-based pricing, rebate negotiations, and transparent pricing laws can modify the net market price, either stabilizing higher prices for high-value drugs or driving prices downward through negotiation policies.
4. Can new indications alter the price trajectory for NDC 51672-4217?
Yes. Additional approved uses can expand the patient population, increasing demand and allowing manufacturers to justify higher or sustained prices. Conversely, if new indications disrupt existing markets or lead to off-label competition, prices could decline.
5. How should stakeholders approach procurement strategies for this drug?
Stakeholders should conduct periodic market assessments, consider long-term contractual arrangements before patent expiry, and evaluate alternative therapies. Aligning procurement with patent timelines and market dynamics optimizes cost management and product availability.
References:
- U.S. Food and Drug Administration (FDA). Drug Approvals and Regulatory Status.
- IQVIA Institute. (2022). The Global Use of Medicine in 2022.
- Express Scripts. (2023). 2019 Drug Trend Report.
- Deloitte Insights. (2021). The Future of Pharma Pricing.
- FDA's Orange Book. (2023). Patent Data and Market Exclusivity.
This report serves as an analytical foundation for strategic decision-making related to NDC 51672-4217. Stakeholders should consider integrating dynamic market intelligence and legislative updates to refine projections continually.
